Exhibit 10.1
Friday, February 4th, 2022
Marc Grasso, MD
1607 Willow Avenue
Burlingame CA 94010
mgrasso353@gmail.com
Mobile: (917) 690-1994
Dear Marc,
On behalf of Alector, LLC (the “Company”), we are very pleased to provide this offer of employment as Chief Financial Officer and to set forth the terms of your employment with the Company. As part of the Alector team, you will play a vital role in our mission to develop therapies that empower the immune system to cure neuro-degeneration and cancer.
Page 1 of NUMPAGES 6
These option grants shall be subject to the terms and conditions of the Company’s Equity Incentive Plan and applicable Stock Option Agreement, Restricted Stock Agreement or Performance Share Agreement, including vesting requirements (the “Equity Agreements”). No right to any equity is earned or accrued until such time that vesting occurs, nor does the grant confer any right to continue vesting or employment. In the event of any conflict between the terms of this offer letter and the Equity Incentive Plan and the Equity Agreements, the terms of the Equity Agreements shall prevail, with one specific exception to this being the removal of the one-year cliff for your new hire grant (as detailed in 7.a.).
Page 2 of NUMPAGES 6
Page 3 of NUMPAGES 6
We are excited by the prospect of you joining us as Alector. If you have any questions, please do not hesitate to reach out.
To accept the Company’s offer, please sign and date this letter in the space provided below.
This letter and its attachments, along with any agreements relating to proprietary rights between you and the Company, set forth the terms of your employment with the Company and supersede any prior representations or agreements including, but not limited to, any representations made during your recruitment, interviews or pre-employment negotiations, whether written or oral, and including our prior offer of employment that was signed and dated January 9th, 2022. This letter, including, but not limited to, its at-will employment provision, may not be modified or amended except by a written agreement signed by the CEO of the Company and you. This offer of employment will terminate if it is not accepted, signed and returned by 6:00pm Pacific Time on Sunday, February 6th, 2022.
Page 4 of NUMPAGES 6
We look forward to your favorable reply and to working with you at Alector.
Sincerely,
/s/ Arnon Rosenthal
Arnon Rosenthal, PhD
Co-Founder and CEO
Agreed to and accepted:
Signature: /s/ Marc Grasso Date: February 4, 2022
Marc Grasso, MD
Enclosures:
At-Will Employment, Confidential Information, and Invention Assignment Agreement
Mutual Dispute Resolution Agreement
Page 5 of NUMPAGES 6